Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Hepatology
•
Viral Hepatitis
What kind of monitoring do you choose in patients at risk for reactivation of hepatitis B who are on immunosuppression?
Related Questions
How do you explain the additional risks that a transplant recipient may carry by pursuing a hepatitis C positive organ if they are negative?
In what scenarios do you defer treatment of a patient's hepatitis C if they are undergoing liver transplant evaluation?
What role is there for the use of ursodiol in relapsing hepatitis A for management of liver enzyme abnormalities and patient symptoms?
All things being equal, what patient factors are you looking at in the selection of TAF or TDF in the management of hepatitis B?
How do you approach restarting immunotherapy in a patient with metastatic melanoma who previously developed immune-mediated hepatitis (Grade 3), with liver enzymes now back to baseline levels?
What variables do you weigh most heavily when choosing which copper chelation therapy you'll recommend for a patient?
What is your approach to a patient with an elevated alkaline phosphatase level, but negative PBC serologies and normal biliary imaging?
What is your evaluation approach for a new patient referral for an incidentally found liver lesion?
How do you approach fertility/family planning and counseling in patients with end-stage liver disease?
How would you approach a referral for concern for hemochromatosis with ferritin elevation but otherwise normal iron studies?
